- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01056224
Effect of Remifentanil Boluses on Hemodynamics in Skull Pin Insertion
The Dose Effects of Remifentanil Boluses on the Hemodynamic Response to Skull Pin Insertion.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Skull pin insertion is commonly required for craniotomies and cervical spine surgery. It is a brief but highly stimulating maneuver performed following induction, during a period of light anesthesia, and may cause significant rise in blood pressure, heart rate and intracranial pressure if not anticipated and treated.
A wide variety of methods have been shown to be effective at blunting this hypertensive response. These include intravenous agents such as fentanyl, sufentanil, clonidine, ketamine and magnesium sulphate, local anesthetic methods such as injection at pin sites or full scalp blocks, deepening the volatile agent, oral premedication or a combination of these methods. There is no consensus on which of these methods is the best. Many anesthesiologists simply use boluses of propofol - a reliable way of accomplishing this effect with a familiar drug. It is also very common for anesthesiologists to use remifentanil, by increasing the infusion rate and or bolusing.
Remifentanil is an ultra-short acting opiate with such rapid onset and offset, that it is most easily and safely delivered by infusion. Increasingly in the literature, however, are reports of remifentanil administered as boluses rather than infusions. Boluses may be ideal for very short stimulating procedures such as intubation and skull pin fixation where a quick onset and offset are desired. Although the safety of bolusing remifentanil has been established in many studies , some authors are still apprehensive . Care must be taken to avoid bolusing with greater doses than required since this may lead to bradycardia and hypotension. In non-ventilated patients, respiratory depression is common and chest wall rigidity may occur at doses larger than 4ug/kg9.
Different bolus dose-effect studies have recommended the following for remifentanil in a variety of clinical settings:
- 3-5ug/kg with propofol 2mg/kg for intubation without muscle relaxants ,
- 2ug/kg with propofol TCI (>4ug/ml) and cisatracurium for intubation (no additional hemodynamic benefit using 4ug/kg)
- 1-1.25ug/kg for rapid sequence intubation with thiopentone 5-7mg/kg and succinylcholine 1mg/kg
- ED50 of 1.7ug/kg and ED95 of 2.88ug/kg for good to excellent intubating conditions in both infants and children (when used with 10ug/kg glycopyrrolate and 4mg/kg propofol)
- 3ug/kg (plus 4mg/kg propofol) provides similar intubating conditions when used in place of succinylcholine 2mg/kg for intubation in infants8
Remifentanil is not currently recommended for the following settings:
- As a sole agent for loss of consciousness with a high ED50 of 12ug/kg, lack of reliability and muscle rigidity common at such high doses
- Wide interindividual variability limit its use for labor analgesia (0.2-0.8ug/kg, median dose of 0.4ug/kg)
In neurosurgery, it is common to administer remifentanil as an infusion. Optimal infusion rates have already been investigated for intracranial surgery . However it is increasingly common to administer remifentanil as a bolus particularly during skull pin fixation, due to the desirable quick onset and offset, and there are no studies at present that have investigated optimal dose requirements for boluses in this setting.
At our institution we commonly administer remifentanil as a bolus during skull pin fixation and are interested in determining which bolus doses are safe and effective
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Ontario
-
Toronto, Ontario, Kanada, M5T 2S8
- Toronto Western Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Patients requiring skull pin fixation and general anesthesia for:
- Elective cervical spine surgery
- Elective craniotomies/brain tumor resection
- Elective transsphenoidal pituitary hypophysectomies
Exclusion Criteria:
Patients with evidence of raised intracranial pressure:
- GSC < 15
- Radiological evidence of significant rise in ICP (e.g. midline shift)
- Vascular anomalies in the brain
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Fyrdubbla
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: 1.25 ug/kg normo-tensive 20-40 year olds
A single bolus dose of 1.25 micrograms per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 20 to 40 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.5 ug/kg normo-tensive 20-40 year olds
A single bolus dose of 1.5 micrograms per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 20 to 40 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.75 ug/kg normo-tensive 20-40 year olds
A single bolus dose of 1.75 micrograms per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 20 to 40 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1 ug/kg normo-tensive 65-75 year olds
A single bolus dose of 1 microgram per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 65 to 75 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.25 ug/kg normo-tensive 65-75 year olds
A single bolus dose of 1.25 micrograms per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 65 to 75 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.5 ug/kg normo-tensive 65-75 year olds
1.5 ug/kg normo-tensive 65-75 year olds A single bolus dose of 1.5 micrograms per kilogram body weight will be administered at the time of skull pin insertion in normo-tensive patients aged 65 to 75 years old. |
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1 ug/kg hyper-tensive 65-75 year olds
A single bolus dose of 1 microgram per kilogram body weight will be administered at the time of skull pin insertion in hyper-tensive patients aged 65 to 75 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.25 ug/kg hyper-tensive 65-75 year olds
A single bolus dose of 1.25 micrograms per kilogram body weight will be administered at the time of skull pin insertion in hyper-tensive patients aged 65 to 75 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Experimentell: 1.5 ug/kg hyper-tensive 65-75 year olds
A single bolus dose of 1.5 micrograms per kilogram body weight will be administered at the time of skull pin insertion in hyper-tensive patients aged 65 to 75 years old.
|
A single bolus dose of Remifentanil will be administered at the time of skull pin insertion
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
To validate the safety and effectiveness of using remifentanil as a bolus for skull pin fixation
Tidsram: 10 minutes
|
10 minutes
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
To determine the optimal doses for remifentanil in order to blunt the hemodynamic changes associated with skull pin fixation
Tidsram: 10 minutes
|
10 minutes
|
to assess variability in dose requirements of remifentanil
Tidsram: 10 minutes
|
10 minutes
|
to compare the dose effects in younger (20-40yo) vs. older (65-75yo) age groups
Tidsram: 10 minutes
|
10 minutes
|
to compare the dose effects in older (65-75yo) age groups in hypertensive versus non-hypertensive patients
Tidsram: 10 minutes
|
10 minutes
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Atul Prabhu, MD, University Health Network, Toronto
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 05-0684-B
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Skull Pin Insättning
-
Assiut UniversityOkänd
-
Kaohsiung Medical University Chung-Ho Memorial...AvslutadLuftvägssjuklighet | Anestesi Insertion KomplikationTaiwan
-
Khon Kaen UniversityAvslutadHemodynamisk respons | Skull Pins ApplikationThailand
-
M.D. Anderson Cancer CenterRekrytering
-
University of PittsburghRekryteringSkull Base Neoplasm | Cellulär patologiFörenta staterna
-
Baptist Health South FloridaNicklaus Children's Hospital f/k/a Miami Children's HospitalAktiv, inte rekryterandeHjärncancer | Hjärntumör | Skull Base TumörFörenta staterna
-
Massachusetts General HospitalNational Cancer Institute (NCI)AvslutadHjärntumör | Tumör i huvud och hals | Skull Base TumörFörenta staterna
-
Ricardo L. Carrau, MDOkändSkull Base PatologiFörenta staterna
-
Yongchang ZhangRekryteringHER2 Insertion Mutation Positiv Advanced NSCLCKina
-
Icahn School of Medicine at Mount SinaiNX Development CorpRekryteringNeoplasm | Skull Base NeoplasmFörenta staterna
Kliniska prövningar på Remifentanil
-
University Medical Center GroningenAvslutadAnestesi | Hemodynamisk instabilitet | Samspel | Störning av syretransportNederländerna
-
Inje UniversityAvslutadStrabismusKorea, Republiken av
-
Ciusss de L'Est de l'Île de MontréalAvslutadIntubation; Svårt eller misslyckatKanada
-
Helse FonnaAvslutadAnestesi, general | Anestesi, intravenöst | Hemodynamisk instabilitetNorge
-
Hopital FochAvslutadAllmän anestesiFrankrike
-
Seoul National University HospitalAjou University School of Medicine; Severance HospitalAvslutadSpädbarn, för tidigt föddaKorea, Republiken av
-
Zhang HaopengAvslutad
-
Seoul National University HospitalHar inte rekryterat ännu
-
Centre Hospitalier Universitaire de NīmesAvslutad
-
Erasme University HospitalUniversity of LiegeAvslutadÖverdosering av intravenöst anestesimedel